Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ABVC BioPharma, Inc. - Common Stock (NQ:ABVC)

0.9145 -0.1955 (-17.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 499,108
Open 1.100
Bid (Size) 0.9145 (1)
Ask (Size) 0.9146 (6)
Prev. Close 1.110
Today's Range 0.9000 - 1.170
52wk Range 0.4000 - 1.730
Shares Outstanding 24,420,526
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Economy
Exposures Supply Chain
ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million
FREMONT, CA - April 3, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative treatments in ophthalmology, CNS (central nervous... 
Via TheNewswire.com
Topics Economy
Exposures Supply Chain

Performance

YTD
+42.6%
+42.6%
1 Month
+32.5%
+32.5%
3 Month
+42.6%
+42.6%
6 Month
+51.1%
+51.1%
1 Year
-29.1%
-29.1%

More News

Read More
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees
Via TheNewswire.com
Top stock movements in today's session.
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
ABVC BioPharma Maintains Lucrative Global Licensing Agreements and Promising CDMO Acquisition, Strengthening Growth Potential
Via NewMediaWire
ABVC BioPharma Maintains Lucrative Global Licensing Agreements and Promising CDMO Acquisition, Strengthening Growth Potential
Via TheNewswire.com
ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs
Via NewMediaWire
Topics Economy
Exposures Supply Chain
ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs
Via TheNewswire.com
Topics Economy
Exposures Supply Chain
ABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global Markets
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
ABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global Markets
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Which stocks have an unusual volume on Monday?
Via Chartmill
On Friday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025
Via TheNewswire.com
ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025
Via NewMediaWire
Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into Global Dietary Supplements Market of USD 75.35 Billion
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into Global Dietary Supplements Market of USD 75.35 Billion
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Via NewMediaWire
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Via TheNewswire.com
ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market
Via NewMediaWire
ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market
Via TheNewswire.com
AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees
Via NewMediaWire
ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement
Via NewMediaWire
ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement
Via TheNewswire.com

Frequently Asked Questions

Is ABVC BioPharma, Inc. - Common Stock publicly traded?
Yes, ABVC BioPharma, Inc. - Common Stock is publicly traded.
What exchange does ABVC BioPharma, Inc. - Common Stock trade on?
ABVC BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ABVC BioPharma, Inc. - Common Stock?
The ticker symbol for ABVC BioPharma, Inc. - Common Stock is ABVC on the Nasdaq Stock Market
What is the current price of ABVC BioPharma, Inc. - Common Stock?
The current price of ABVC BioPharma, Inc. - Common Stock is 0.9145
When was ABVC BioPharma, Inc. - Common Stock last traded?
The last trade of ABVC BioPharma, Inc. - Common Stock was at 04/03/25 04:00 PM ET
What is the market capitalization of ABVC BioPharma, Inc. - Common Stock?
The market capitalization of ABVC BioPharma, Inc. - Common Stock is 22.33M
How many shares of ABVC BioPharma, Inc. - Common Stock are outstanding?
ABVC BioPharma, Inc. - Common Stock has 22M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.